Victoria, BC – A University of Victoria researcher hopes to change the nature of testing for heart disease, cancer and drug toxicity using a highly sensitive and fast machine that would only require a single drop of blood from a patient. Called a mass spectrometer, this machine determines the weight of protein molecules in the […]
SCOTTSDALE, AZ – Health Enhancement Products, Inc. (OTCBB: HEPI) has contracted the analytical services arm of scientific instrument maker Bruker Corporation, based in Billerica, MA, to conduct liquid chromatography, nuclear magnetic resonance and mass spectroscopy on the final remaining isolates identified by the HEPI research team over the last year. This latest news caps months […]
MANCHESTER, England – Waters Corporation (NYSE: WAT) today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry (MS) Headquarters in Wilmslow, Cheshire, near Manchester, U.K. Situated on the 37-acre Stamford Lodge site on the A538 Wilmslow/Altrincham road, three miles south of Manchester Airport the new facility is […]
Biomarker Assay Services in Drug Development Rockville, MD – Expression Pathology Inc. announced an agreement with Roche (SIX:RO, ROG; OTCQX:RHHBY) wherein Expression Pathology will provide its Liquid Tissue®- SRM Technology to accelerate identification of cancer molecular markers for developing more effective treatments. Under the terms of the agreement, Expression Pathology will support Roche oncology drug […]
Xevo G2 Tof Delivers Most Sensitive, Exact Mass, Quantitative and Qualitative Performance of any Benchtop MS System MILFORD, Mass. – Waters Corporation (NYSE: WAT) today introduced the Waters(R) Xevo(R) G2 Tof (time-of-flight) mass spectrometer (MS) with UPLC(R)/MS(E) and QuanTof(TM) technology, which offers the most sensitive, exact mass quantitative and qualitative performance of any benchtop MS […]
MILWAUKEE – Bruker today announced that Dynacare Laboratories in Milwaukee, Wisconsin (www.dynacaremilwaukee.com), after careful internal evaluation, has purchased a Bruker MALDI Biotyper system as their next-generation rapid microbial identification system. The MALDI Biotyper has obtained the IVD-CE Mark in selected European countries, and Bruker is planning to submit the MALDI Biotyper to the U.S. FDA […]
Bolton, Ontario – David Tilson, Member of Parliament for Dufferin-Caledon, today announced a total contribution of $173,233 to four Bolton firms from the National Research Council Industrial Research Assistance Program. The funding support was provided to the following firms: IONICS Mass Spectrometry Group, Inc., Silcotech North America Inc., MSdetection Corp., and Technoject Machinery Corp. from […]
Burlingame, CA – Epitomics and NCI to Develop Novel Antibodies Using Epitomics Technology Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) […]
Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Dionex Corporation (“Dionex” or the “Company”) (Nasdaq: DNEX) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Thermo Fisher Scientific in a transaction with […]
SANTA CLARA, Calif., and PRINCETON, N. J. – The Agilent Technologies Foundation today announced that David Botstein and his colleagues, Joshua Rabinowitz, Benjamin Garcia and Leonid Kruglyak, received an Agilent Thought Leader Award in support of their work in systems biology. Dr. Botstein is professor and director of the Lewis-Sigler Institute for Integrative Genomics and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
